Close Menu

NEW YORK – Natera on Tuesday sued molecular diagnostics and consulting firm Genosity for alleged patent infringement relating to technology from ArcherDx.

In its complaint, filed with the US District Court for the District of Delaware, Natera claimed that several of Genosity's products infringe its US Patent No. 10,732,220, titled "Methods for Simultaneous Amplification of Target Loci."

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.